Planta Med 2016; 82(13): 1180-1185
DOI: 10.1055/s-0042-106169
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Overcoming Multidrug Resistance in Candida albicans: Macrocyclic Diterpenes from Euphorbia Species as Potent Inhibitors of Drug Efflux Pumps

Shweta Nim
1   School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
,
Andreia Mónico
2   Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal
,
Manpreet Kaur Rawal
1   School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
,
Noélia Duarte
2   Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal
,
Rajendra Prasad
1   School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
3   Amity Institute of Integrative Sciences and Health, AMITY University, Education Valley, Gurgaon, India
,
Attilio Di Pietro*
4   BMSSI UMR5086 CNRS and University of Lyon, IBCP, Lyon, France
,
Maria-José U. Ferreira*
2   Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal
› Author Affiliations
Further Information

Publication History

received 09 February 2016
revised 23 March 2016

accepted 03 April 2016

Publication Date:
04 May 2016 (online)

Abstract

Thirteen macrocyclic diterpenes (113) of the jatrophane and lathyrane types, either isolated from Euphorbia species or obtained by chemical derivatization, were evaluated for their ability to inhibit the drug efflux activity of Candida albicans CaCdr1p and CaMdr1p multidrug transporters overexpressed in a Saccharomyces cerevisiae strain. Their inhibitory potential was assessed through a functional assay of Nile Red accumulation monitored by flow cytometry. A chemosensitization assay, using the checkerboard method, was also performed with the active compounds in order to evaluate their type of interaction with fluconazole.

In the transport assay, most compounds were found to inhibit both transporters, most likely as non-substrates, as shown by relative resistance indices close to unity. In contrast, the jatrophanes euphopubescenol (10) and euphomelliferene A (11) were selective for CaMdr1p and CaCdr1p, respectively. Moreover, when used in combination with fluconazole, compounds 12 and 13 displayed strong synergistic interactions (FICI = 0.071) against the yeast strain overexpressing CaMdr1p, decreasing the MIC80 of the antifungal agent 13-fold. Both compounds were also able to reduce the effective concentration of this antifungal agent by 4- to 8-fold against an azole-resistant clinical isolate of C. albicans (F5).

* Coauthors.


Supporting Information

 
  • References

  • 1 Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56: i5-i11
  • 2 Hedderwick S, Kauffman CA. Opportunistic fungal infections: superficial and systemic candidiasis. Geriatrics 1997; 52: 50-54
  • 3 Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 2008; 46: 150-156
  • 4 Perlin DS. Current perspectives on echinocandin class drugs. Future Microbiol 2011; 6: 441-457
  • 5 Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-517
  • 6 Cannon RD, Lamping E, Holmes AR, Niimi K, Baret FV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009; 22: 291-321
  • 7 Sanguinetti M, Posteraro B, Lass-Flörl C. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses 2015; 58: 2-13
  • 8 Prasad R, Goffeau A. Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu Rev Microbiol 2012; 66: 39-63
  • 9 Rawal MK, Khan MF, Kapoor K, Goyal N, Sen S, Saxena AK, Lynn AM, Tyndall JD, Monk BC, Cannon RD, Komath SS, Prasad R. Insight into pleiotropic drug resistance ATP-binding cassette pump drug transport through mutagenesis of Cdr1p transmembrane domains. J Biol Chem 2013; 288: 24480-24493
  • 10 Tanabe K, Lamping E, Adachi K, Takano Y, Kawabata K, Shizuri Y, Niimi M, Uehara Y. Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium. Biochem Biophys Res Commun 2007; 364: 990-995
  • 11 Nim S, Rawal MK, Prasad R. FK520 interacts with the discrete intrahelical amino acids of multidrug transporter Cdr1 protein and acts as antagonist to selectively chemosensitize azole-resistant clinical isolates of Candida albicans . FEMS Yeast Res 2014; 14: 624-632
  • 12 Sharma M, Prasad R. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans . Antimicrob Agents Chemother 2011; 55: 4834-4843
  • 13 Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, Ambudkar SV, Prasad R. Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob Agents Chemother 2009; 53: 3256-3265
  • 14 Shukla S, Sauna ZE, Prasad R, Ambudkar SV. Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans . Biochem Biophys Res Commun 2004; 322: 520-525
  • 15 Ivnitski-Steele I, Holmes AR, Lamping E, Monk BC, Cannon RD, Sklar LA. Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. Anal Biochem 2009; 394: 87-91
  • 16 Basso Jr. LR, Gast CE, Mao Y, Wong B. Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p. Eukaryot Cell 2010; 9: 960-970
  • 17 Keniya MV, Fleischer E, Klinger A, Cannon RD, Monk BC. Inhibitors of the Candida albicans major facilitator superfamily transporter Mdr1p responsible for fluconazole resistance. PLoS One 2015; 10: e0126350
  • 18 Ferreira MJU, Duarte N, Reis M, Madureira AM, Molnár J. Euphorbia and Momordica metabolites for overcoming multidrug resistance. Phytochem Rev 2014; 13: 915-935
  • 19 Duarte N, Gyémánt N, Abreu P, Molnár J, Ferreira MJU. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumor cells. Planta Med 2006; 72: 162-168
  • 20 Duarte N, Lage H, Ferreira MJU. Three new jatrophane diterpene polyesters and antiproliferative constituents from Euphorbia tuckeyana . Planta Med 2008; 74: 61-68
  • 21 Valente C, Ferreira MJU, Abreu P, Pedro M, Cerqueira F, Nascimento M. Three new jatrophane-type diterpenes from Euphorbia pubescens . Planta Med 2003; 69: 361-366
  • 22 Valente C, Pedro M, Ascenso J, Abreu P, Nascimento M, Ferreira MJU. Euphopubescenol and euphopubescene, two new jatrophane polyesters, and lathyrane type diterpenes from Euphorbia pubescens . Planta Med 2004; 70: 244-249
  • 23 Valente I, Reis M, Duarte N, Serly J, Molnár J, Ferreira MJU. Jatrophane diterpenes from Euphorbia mellifera and their activity as P-glycoprotein modulators on multidrug resistant mouse lymphoma and human colon adenocarcinoma cells. J Nat Prod 2012; 75: 1915-1921
  • 24 Ferreira RJ, dos Santos DJ, Ferreira MJU, Guedes RC. Toward a better pharmacophore description of P-glycoprotein modulators, based on macrocyclic diterpenes from Euphorbia species. J Chem Inf Model 2011; 51: 1315-1324
  • 25 Sousa IJ, Ferreira MJU, Molnár J, Fernandes MX. QSAR studies of macrocyclic diterpenes with P-glycoprotein inhibitory activity. Eur J Pharm Sci 2013; 48: 542-553
  • 26 Rawal MK, Shokoohinia Y, Chianese G, Zolfaghari B, Appendino G, Taglialatela-Scafati O, Prasad R, Di Pietro A. Jatrophanes from Euphorbia squamosa as potent inhibitors of Candida albicans multidrug transporters. J Nat Prod 2014; 77: 2700-2706
  • 27 Duarte N, Járdánházy A, Molnár J, Hilgeroth A, Ferreira MJU. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells. Bioorg Med Chem 2008; 16: 9323-9330
  • 28 Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, Morschhäuser J. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 1998; 42: 3065-3072
  • 29 Franz R, Ruhnke M, Morschhäuser J. Molecular aspects of fluconazole resistance development in Candida albicans . Mycoses 1999; 42: 453-458
  • 30 White RL, Burgess DS, Mandruru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard and E-test. Antimicrob Agents Chemother 1996; 40: 1914-1918
  • 31 Odds FC. Synergy, antagonism, and what the checkerboard puts between them. J Antimicrob Chemother 2003; 52: 1
  • 32 Corea G, Di Pietro A, Dumontet C, Fattorusso E, Lanzotti V. Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy. Phytochem Rev 2009; 8: 431-447
  • 33 Vasas A, Rédei D, Csupor D, Molnár J, Hohmann J. Diterpenes from European Euphorbia species serving as prototypes for natural-product-based drug discovery. European J Org Chem 2012; 27: 5115-5130
  • 34 Reis M, Ferreira RJ, Santos MM, dos Santos DJ, Molnár J, Ferreira MJU. Enhancing macrocyclic diterpenes as multidrug-resistance reversers: structure-activity studies on jolkinol D derivatives. J Med Chem 2013; 56: 748-760
  • 35 Vieira C, Duarte N, Reis MA, Spengler G, Madureira AM, Molnár J, Ferreira MJU. Improving the MDR reversal activity of 6, 17-epoxylathyrane diterpenes. Bioorg Med Chem 2014; 22: 6392-6400
  • 36 VCCLAB, Virtual Computational Chemistry Laboratory. Available at. http://www.vcclab.org Accessed November 2, 2015